Abstract: The incidence of multi-drug resistant bacterial species is rapidly increasing. To avoid antibiotic misuse and further exacerbation of this health crisis, clinicians should obtain a swift and ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback